NCT07610031Recruiting
Trunk Control Exercises and Mirror Therapy on Balance and Posture in Parkinson's Disease
Effects of Trunk Control Exercises and Mirror Therapy on Balance and Posture in Patients With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
Parkinson's disease (PD) is movement disorder of the nervous system that worsens over time. As nerve cells (neurons) in parts of the brain weaken or are damaged or die, people may begin to notice problems with movement, tremor, stiffness in the limbs or the trunk of the body, or impaired balance. As these symptoms become more obvious, people may have difficulty walking, talking, or completing other simple tasks. Not everyone with one or more of these symptoms has PD, as the symptoms appear in other diseases as well. Both non-modifiable (age, gender) and modifiable risk factors such as occupation, exposure to pesticides, and depression have an association with PD. Several studies have suggested that Parkinson disease is more common in men. The MT mechanism is based on the concept of visual illusion. The movement of the non-paretic part in front of the mirror (reflective side) is perceived as that of the paretic body part (hidden beside the mirror). MT allows an individual to have an experience of normal movement, even for the severely paralyzed limb. In addition, wherever other rehabilitation methods fail to induce normal movements without any compensation, MT may act as a foundation step for further motor therapy. The perception of movement illusion, a neuropsychological phenomenon may induce neural activation of the lesioned brain and enhance associated motor recovery. Therefore the aim of this study is to compare the effects of truck control exercise program and mirror therapy on balance and postural instability in patients with Parkinson's disease.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 8 Sept 2025
- Start date
- 22 Dec 2024
- Primary completion date
- 15 Jun 2026
- Lead sponsor
- University of Lahore
- Diseases
- Parkinson disease
- NCT number
- NCT07610031
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 22 Dec 2024 to the primary completion date, 15 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Patient having any recent episode of epilepsy(Bomasang-Layno et al., 2015)
- Patient has had any recent trauma. (Hong et al., 2009)
- Individuals free from chronic diseases such as unstable cardiovascular disease that could compromise their safety during training or testing (Hoffmann et al., 2016).
Who the study is looking for
- • 50-70 age(Bomasang-Layno et al., 2015)
- Both genders (Bomasang-Layno et al., 2015)
- Patient with grade 1,2,3 Parkinsonism (according to Hoehn and Yahr scale)
- Patient taking fixed dose of medicines
- No cognitive impairment (according to Mini-Mental scale 24-30 scoring) (Capecci et al., 2014)
- The patient was able to get out of chairs and beds without assistance (Hoffmann et al., 2016).
- Individuals without significant dyskinesias or "on-off" periods.(Lötzke et al., 2015)
Age in the registry: 50 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nimra Nadeem Coordinator of this site? Confirm its status | Lahore | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.